Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 GFR Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus
jRCT2080221750Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bardoxolone methyl in chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM), sponsored by Kyowa Kirin.
02
Drugs
bardoxolone methyl
03
Conditions
chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221750.